Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
Fly Intel: Top five analyst initiations » 10:09
07/02/20
07/02
10:09
07/02/20
10:09
FLIR

Flir Systems

$41.60 /

+0.71 (+1.74%)

, PEAK

Healthpeak

$29.02 /

+0.18 (+0.62%)

, TRHC

Tabula Rasa HealthCare

$55.08 /

+0.79 (+1.46%)

, APDN

Applied DNA Sciences

$8.11 /

+0.36 (+4.65%)

, ES

Eversource

$85.32 /

+0.19 (+0.22%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Flir Systems (FLIR) initiated with a Buy at Canaccord. 2. Healthpeak (PEAK) initiated with a Hold at Berenberg. 3. Tabula Rasa HealthCare (TRHC) initiated with a Buy at SunTrust. 4. Applied DNA Sciences (APDN) initiated with a Buy at H.C. Wainwright. 5. Eversource (ES) assumed with an Underweight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
TRHC Tabula Rasa HealthCare
$55.08 /

+0.79 (+1.46%)

PEAK Healthpeak
$29.02 /

+0.18 (+0.62%)

FLIR Flir Systems
$41.60 /

+0.71 (+1.74%)

ES Eversource
$85.32 /

+0.19 (+0.22%)

APDN Applied DNA Sciences
$8.11 /

+0.36 (+4.65%)

FLIR Flir Systems
$41.60 /

+0.71 (+1.74%)

07/02/20 Canaccord
Flir Systems initiated with a Buy at Canaccord
05/13/20 Imperial Capital
Flir Systems price target raised to $52 from $45 at Imperial Capital
04/20/20 Raymond James
Flir investor investor interest rightfully picking up, says Raymond James
04/20/20 William Blair
William Blair says Flir should benefit from 'major trend' toward thermal cameras
PEAK Healthpeak
$29.02 /

+0.18 (+0.62%)

07/02/20 Citi
Healthpeak price target raised to $28 from $24 at Citi
07/02/20 Berenberg
Healthpeak initiated with a Hold at Berenberg
05/14/20 RBC Capital
Healthpeak price target lowered to $27 from $32 at RBC Capital
04/29/20 Raymond James
Healthpeak downgraded to Market Perform from Outperform at Raymond James
TRHC Tabula Rasa HealthCare
$55.08 /

+0.79 (+1.46%)

07/02/20 SunTrust
Tabula Rasa HealthCare initiated with a Buy at SunTrust
07/02/20 SunTrust
Tabula Rasa HealthCare initiated with a Buy at SunTrust
06/25/20 Cantor Fitzgerald
Tabula Rasa HealthCare price target lowered to $83 from $85 at Cantor Fitzgerald
04/20/20 RBC Capital
Tabula Rasa HealthCare initiated with an Outperform at RBC Capital
APDN Applied DNA Sciences
$8.11 /

+0.36 (+4.65%)

07/02/20 H.C. Wainwright
Applied DNA Sciences initiated with a Buy at H.C. Wainwright
05/05/20 Maxim
Applied DNA Sciences price target raised to $18 from $8 at Maxim
11/22/19
Fly Intel: Top five analyst upgrades
11/22/19 Maxim
Applied DNA Sciences upgraded to Buy from Hold at Maxim
ES Eversource
$85.32 /

+0.19 (+0.22%)

07/02/20 Morgan Stanley
Eversource assumed with an Underweight at Morgan Stanley
05/20/20 Seaport Global
Seaport Global starts Eversource at Buy with $88 price target
05/20/20 Seaport Global
Eversource initiated with a Buy at Seaport Global
05/12/20
Fly Intel: Top five analyst upgrades
TRHC Tabula Rasa HealthCare
$55.08 /

+0.79 (+1.46%)

PEAK Healthpeak
$29.02 /

+0.18 (+0.62%)

FLIR Flir Systems
$41.60 /

+0.71 (+1.74%)

ES Eversource
$85.32 /

+0.19 (+0.22%)

  • 11
    Jun
  • 05
    Nov
FLIR Flir Systems
$41.60 /

+0.71 (+1.74%)

FLIR Flir Systems
$41.60 /

+0.71 (+1.74%)

APDN Applied DNA Sciences
$8.11 /

+0.36 (+4.65%)

FLIR Flir Systems
$41.60 /

+0.71 (+1.74%)

APDN Applied DNA Sciences
$8.11 /

+0.36 (+4.65%)

Initiation
Applied DNA Sciences initiated with a Buy at H.C. Wainwright » 06:05
07/02/20
07/02
06:05
07/02/20
06:05
APDN

Applied DNA Sciences

$7.75 /

-0.27 (-3.37%)

H.C. Wainwright analyst…

H.C. Wainwright analyst Yi Chen initiated coverage of Applied DNA Sciences with a Buy rating and $18 price target. The company's COVID-19 vaccine candidates have produced neutralizing antibodies in mice and results from the linear DNA version in animal studies are slated to be reported in the coming days, Chen tells investors in a research note. The analyst cites Applied's "rapid responses and the substantial markets of COVID-19 testing" for the Buy rating.

ShowHide Related Items >><<
APDN Applied DNA Sciences
$7.75 /

-0.27 (-3.37%)

APDN Applied DNA Sciences
$7.75 /

-0.27 (-3.37%)

05/05/20 Maxim
Applied DNA Sciences price target raised to $18 from $8 at Maxim
11/22/19
Fly Intel: Top five analyst upgrades
11/22/19 Maxim
Applied DNA Sciences upgraded to Buy from Hold at Maxim
APDN Applied DNA Sciences
$7.75 /

-0.27 (-3.37%)

APDN Applied DNA Sciences
$7.75 /

-0.27 (-3.37%)

Over a week ago
Options
Two new option listings and ten option delistings on June 22nd » 08:30
06/22/20
06/22
08:30
06/22/20
08:30
APDN

Applied DNA Sciences

$7.45 /

+0.16 (+2.19%)

, CGIX

Cancer Genetics

$3.43 /

-0.04 (-1.15%)

, FDEF

First Defiance Financial

$0.00 /

+ (+0.00%)

, NIHD

NII Holdings

$2.16 /

+ (+0.00%)

, SDRL

Seadrill

$0.51 /

-0.0358 (-6.55%)

New option listings for…

New option listings for June 22nd include Premier Financial Corporation (PFC) and Seadrill Ltd (SDRLF). Option delistings effective June 22nd include Applied DNA Sciences (APDN), Cancer Genetics (CGIX), CARBO Ceramics Inc (CRRTQ), First Defiance Financial Corporation (FDEF), Morningstar Dividend (FDL), Foresight Energy Partners LP (Units) (FELPQ), Hornbeck Offshore Services Inc (HOSSQ), NII Holdings (NIHD), Seadrill Ltd (SDRL), and Sandridge Mississippian Trust II (Units) (SDRMU).

ShowHide Related Items >><<
SDRL Seadrill
$0.51 /

-0.0358 (-6.55%)

FDEF First Defiance Financial
$0.00 /

+ (+0.00%)

CGIX Cancer Genetics
$3.43 /

-0.04 (-1.15%)

APDN Applied DNA Sciences
$7.45 /

+0.16 (+2.19%)

APDN Applied DNA Sciences
$7.45 /

+0.16 (+2.19%)

05/05/20 Maxim
Applied DNA Sciences price target raised to $18 from $8 at Maxim
11/22/19
Fly Intel: Top five analyst upgrades
11/22/19 Maxim
Applied DNA Sciences upgraded to Buy from Hold at Maxim
CGIX Cancer Genetics
$3.43 /

-0.04 (-1.15%)

FDEF First Defiance Financial
$0.00 /

+ (+0.00%)

06/17/20 Raymond James
First Defiance upgraded to Outperform from Market Perform at Raymond James
06/17/20 Raymond James
First Defiance Financial upgraded to Outperform from Market Perform at Raymond James
09/11/19 Raymond James
United Community downgraded at Raymond James following merger agreement
09/11/19 Sandler O'Neill
First Defiance Financial upgraded to Buy from Hold at Sandler O'Neill
NIHD NII Holdings
$2.16 /

+ (+0.00%)

SDRL Seadrill
$0.51 /

-0.0358 (-6.55%)

05/28/20 Nordea
Seadrill downgraded to Sell from Hold at Nordea
08/13/19
Fly Intel: Top five analyst downgrades
08/13/19 BTIG
Seadrill downgraded to Neutral from Buy at BTIG
SDRL Seadrill
$0.51 /

-0.0358 (-6.55%)

FDEF First Defiance Financial
$0.00 /

+ (+0.00%)

CGIX Cancer Genetics
$3.43 /

-0.04 (-1.15%)

SDRL Seadrill
$0.51 /

-0.0358 (-6.55%)

APDN Applied DNA Sciences
$7.45 /

+0.16 (+2.19%)

NIHD NII Holdings
$2.16 /

+ (+0.00%)

FDEF First Defiance Financial
$0.00 /

+ (+0.00%)

Hot Stocks
Applied DNA announces $40,000 economic development grant for COVID-19 programs » 11:37
06/09/20
06/09
11:37
06/09/20
11:37
APDN

Applied DNA Sciences

$7.50 /

-0.25 (-3.23%)

Applied DNA Sciences…

Applied DNA Sciences announced it secured a $40,000 economic development grant from National Grid to support the company's efforts associated with the manufacture of COVID-19-related therapeutics and diagnostics programs. "We are grateful for National Grid and New York State's focus on the Long Island community in this time of crisis. This funding will be used to increase our capacity to deliver quantities of our RT-PCR test for COVID-19 that was recently approved under Emergency Use Authorization by the FDA for clinical use, and to support the pathway toward human trials of selected vaccine candidates we have jointly developed with Takis Biotech. Our orchestrated approach to our development programs aimed at vanquishing COVID-19 we believe is unique, and we share a deep motivation as fellow Long Islanders to support local communities and governments, that are working tirelessly to manage within the pandemic," said Dr. James Hayward, president and CEO at Applied DNA.

ShowHide Related Items >><<
APDN Applied DNA Sciences
$7.50 /

-0.25 (-3.23%)

APDN Applied DNA Sciences
$7.50 /

-0.25 (-3.23%)

05/05/20 Maxim
Applied DNA Sciences price target raised to $18 from $8 at Maxim
11/22/19
Fly Intel: Top five analyst upgrades
11/22/19 Maxim
Applied DNA Sciences upgraded to Buy from Hold at Maxim
APDN Applied DNA Sciences
$7.50 /

-0.25 (-3.23%)

Hot Stocks
Applied DNA Sciences provides update on linear-DNA COVID-19 vaccine candidates » 08:30
06/08/20
06/08
08:30
06/08/20
08:30
APDN

Applied DNA Sciences

$7.38 /

-0.58 (-7.29%)

Applied DNA Sciences…

Applied DNA Sciences provided an update related to the development of linear-DNA form of COVID-19 vaccine candidates with development partner Takis Biotech. Subsequent to the company's announcement that first injections of plasmid-based DNA vaccine candidates developed by Takis produced neutralizing antibodies in test animals, linear DNA versions of the vaccine candidates manufactured by Applied DNA began dose-response trials the results of which the company expects to publish in June. The companies' development program utilizes the plasmid-based DNA templates to determine baseline results for the efficacy of the vaccine candidates in preclinical animal models. Based on previous studies with its linear-DNA, Applied DNA anticipates similar results from its linear DNA versions of the vaccine candidates in preclinical animal models with the potential added advantage of reduced risk of antibiotic resistance and genomic integration and speed of production.

ShowHide Related Items >><<
APDN Applied DNA Sciences
$7.38 /

-0.58 (-7.29%)

APDN Applied DNA Sciences
$7.38 /

-0.58 (-7.29%)

05/05/20 Maxim
Applied DNA Sciences price target raised to $18 from $8 at Maxim
11/22/19
Fly Intel: Top five analyst upgrades
11/22/19 Maxim
Applied DNA Sciences upgraded to Buy from Hold at Maxim
APDN Applied DNA Sciences
$7.38 /

-0.58 (-7.29%)

Over a month ago
Conference/Events
Maxim Group to hold a virtual conference » 09:25
05/27/20
05/27
09:25
05/27/20
09:25
APDN

Applied DNA Sciences

$11.78 /

+0.69 (+6.22%)

, BIOC

Biocept

$0.50 /

-0.0041 (-0.82%)

, BNGO

Bionano Genomics

$0.50 /

+0.0322 (+6.87%)

, CAPR

Capricor Therapeutics

$5.26 /

-0.13 (-2.41%)

, CODX

Co-Diagnostics

$18.03 /

-0.57 (-3.06%)

, DXR

Daxor

$14.00 /

-0.03 (-0.21%)

, LCTX

Lineage Cell Therapeutics

$1.04 /

+0.1806 (+21.01%)

, MESO

Mesoblast

$12.95 /

+0.76 (+6.23%)

, PSTI

Pluristem

$7.97 /

-0.39 (-4.67%)

, VNRX

VolitionRx

$3.11 /

+0.12 (+4.01%)

Maxim Group Virtual…

Maxim Group Virtual COVID-19 Conference will be held on May 27.

ShowHide Related Items >><<
VNRX VolitionRx
$3.11 /

+0.12 (+4.01%)

PSTI Pluristem
$7.97 /

-0.39 (-4.67%)

MESO Mesoblast
$12.95 /

+0.76 (+6.23%)

LCTX Lineage Cell Therapeutics
$1.04 /

+0.1806 (+21.01%)

DXR Daxor
$14.00 /

-0.03 (-0.21%)

CODX Co-Diagnostics
$18.03 /

-0.57 (-3.06%)

CAPR Capricor Therapeutics
$5.26 /

-0.13 (-2.41%)

BNGO Bionano Genomics
$0.50 /

+0.0322 (+6.87%)

BIOC Biocept
$0.50 /

-0.0041 (-0.82%)

APDN Applied DNA Sciences
$11.78 /

+0.69 (+6.22%)

APDN Applied DNA Sciences
$11.78 /

+0.69 (+6.22%)

05/05/20 Maxim
Applied DNA Sciences price target raised to $18 from $8 at Maxim
11/22/19
Fly Intel: Top five analyst upgrades
11/22/19 Maxim
Applied DNA Sciences upgraded to Buy from Hold at Maxim
BIOC Biocept
$0.50 /

-0.0041 (-0.82%)

05/14/20 Brookline
Biocept initiated with a Buy at Brookline
BNGO Bionano Genomics
$0.50 /

+0.0322 (+6.87%)

04/08/20 Oppenheimer
Oppenheimer bullish on Bionano Genomics, initiates with an Outperform
04/08/20 Oppenheimer
Bionano Genomics initiated with an Outperform at Oppenheimer
CAPR Capricor Therapeutics
$5.26 /

-0.13 (-2.41%)

02/03/20 Maxim
Capricor Therapeutics upgraded to Buy from Hold at Maxim
07/15/19 H.C. Wainwright
Capricor price target raised to $12.40 from $3.50 at H.C. Wainwright
CODX Co-Diagnostics
$18.03 /

-0.57 (-3.06%)

05/20/20 Maxim
Co-Diagnostics upgraded to Buy from Hold at Maxim
05/20/20 Maxim
Co-Diagnostics upgraded to Buy from Hold at Maxim
05/18/20 H.C. Wainwright
Co-Diagnostics price target raised to $35 from $20 at H.C. Wainwright
03/09/20 H.C. Wainwright
Co-Diagnostics price target raised to $20 from $4 at H.C. Wainwright
DXR Daxor
$14.00 /

-0.03 (-0.21%)

09/30/19 Roth Capital
Daxor initiated with a Neutral at Roth Capital
07/29/19
Daxor initiated with a Buy at Maxim
07/29/19 Maxim
Daxor initiated with a Buy at Maxim
LCTX Lineage Cell Therapeutics
$1.04 /

+0.1806 (+21.01%)

05/06/20 H.C. Wainwright
Lineage update shows OpRegen 'nicely on track,' says H.C. Wainwright
MESO Mesoblast
$12.95 /

+0.76 (+6.23%)

04/09/20 H.C. Wainwright
H.C. Wainwright 'encouraged' by Mesoblast's plan to study Ryoncil in ARDS
10/22/19 Cantor Fitzgerald
Mesoblast assumed with an Overweight at Cantor Fitzgerald
09/10/19 Cantor Fitzgerald
Mesoblast partnership deal with Grunenthal a positive, says Cantor Fitzgerald
PSTI Pluristem
$7.97 /

-0.39 (-4.67%)

04/24/20 H.C. Wainwright
Pluristem removed overhang with loan agreement, says H.C. Wainwright
04/13/20 Maxim
Pluristem price target raised to $12 from $8 at Maxim
04/07/20 H.C. Wainwright
Early COVID-19 results 'a game changer' for Pluristem, says H.C. Wainwright
02/10/20 Dawson James
Pluristem could have 'blockbuster' therapy for CLI, says Dawson James
VNRX VolitionRx
$3.11 /

+0.12 (+4.01%)

05/06/20 Aegis
VolitionRx initiated with a Buy at Aegis
LCTX Lineage Cell Therapeutics
$1.04 /

+0.1806 (+21.01%)

CODX Co-Diagnostics
$18.03 /

-0.57 (-3.06%)

CAPR Capricor Therapeutics
$5.26 /

-0.13 (-2.41%)

BNGO Bionano Genomics
$0.50 /

+0.0322 (+6.87%)

CODX Co-Diagnostics
$18.03 /

-0.57 (-3.06%)

VNRX VolitionRx
$3.11 /

+0.12 (+4.01%)

MESO Mesoblast
$12.95 /

+0.76 (+6.23%)

CODX Co-Diagnostics
$18.03 /

-0.57 (-3.06%)

APDN Applied DNA Sciences
$11.78 /

+0.69 (+6.22%)

VNRX VolitionRx
$3.11 /

+0.12 (+4.01%)

PSTI Pluristem
$7.97 /

-0.39 (-4.67%)

MESO Mesoblast
$12.95 /

+0.76 (+6.23%)

CODX Co-Diagnostics
$18.03 /

-0.57 (-3.06%)

CAPR Capricor Therapeutics
$5.26 /

-0.13 (-2.41%)

Syndicate
Applied DNA Sciences files $50M mixed securities shelf  16:10
05/21/20
05/21
16:10
05/21/20
16:10
APDN

Applied DNA Sciences

$11.40 /

+0.1 (+0.88%)

 
ShowHide Related Items >><<
APDN Applied DNA Sciences
$11.40 /

+0.1 (+0.88%)

APDN Applied DNA Sciences
$11.40 /

+0.1 (+0.88%)

05/05/20 Maxim
Applied DNA Sciences price target raised to $18 from $8 at Maxim
11/22/19
Fly Intel: Top five analyst upgrades
11/22/19 Maxim
Applied DNA Sciences upgraded to Buy from Hold at Maxim
APDN Applied DNA Sciences
$11.40 /

+0.1 (+0.88%)

Hot Stocks
Applied DNA Sciences receives FDA EUA for COVID-19 assay kit » 05:35
05/14/20
05/14
05:35
05/14/20
05:35
APDN

Applied DNA Sciences

$8.83 /

-0.48 (-5.16%)

Applied DNA Sciences…

Applied DNA Sciences announced that the FDA has provided Emergency Use Authorization, or EUA, for the clinical use of the company's patent-pending Linea COVID-19 RT-PCR test for COVID-19. Clinical laboratories in the United States certified under Clinical Laboratory Improvement Amendments, or CLIA, to perform hi complexity tests. CLIA labs can immediately begin ordering and using the Linea COVID-19 assay kit to detect SARS-CoV-2, the virus that causes COVID-19. The Linea COVID-19 assay kit is an rRT-PCR-based assay designed to detect specific highly conserved target sequences of the SARS-CoV-2 Spike gene. The Linea COVID-19 assay is an advanced single-well multiplex test that allows for simple set up and higher-throughput as compared to tests that require multiple wells per test. The Linea COVID-19 assay is approved to run on the FDA-approved Applied Biosystems QuantStudio Dx real-time PCR instrument, which allows for testing results for up to 94 samples within one hour, or more than 2,000 tests in 24 hours per device.

ShowHide Related Items >><<
APDN Applied DNA Sciences
$8.83 /

-0.48 (-5.16%)

APDN Applied DNA Sciences
$8.83 /

-0.48 (-5.16%)

05/05/20 Maxim
Applied DNA Sciences price target raised to $18 from $8 at Maxim
11/22/19
Fly Intel: Top five analyst upgrades
11/22/19 Maxim
Applied DNA Sciences upgraded to Buy from Hold at Maxim
APDN Applied DNA Sciences
$8.83 /

-0.48 (-5.16%)

Hot Stocks
Applied DNA Sciences applies to FDA for EUA for COVID-19 diagnostic kit » 09:33
05/05/20
05/05
09:33
05/05/20
09:33
APDN

Applied DNA Sciences

$9.10 /

+2.5 (+37.88%)

Applied DNA Sciences…

Applied DNA Sciences announced that it applied prior to the end of April for U.S. Food and Drug Administration Emergency Use Authorization for its Linea COVID-19 diagnostic candidate to detect SARS-CoV-2, the novel coronavirus that causes the disease COVID-19. Validation for the EUA was completed in collaboration with Stony Brook University Hospital; the company's neighbor and collaborator on campus. The assay is designed to be run in high-throughput workflows that enable same-day results to be transmitted to the ordering physician. In a spirit of continuous innovation and improvement of the end-to-end process of patient diagnosis, the company is investigating methods to enhance the assay to increase the ease of patient sampling by using saliva instead of invasive nasopharyngeal swabbing methods. Applied DNA makes clear that while the company has filed an EUA with the U.S. FDA, the U.S. FDA has not yet approved the company's diagnostic and there is no guarantee that any EUA will be approved. In addition, numerous other SARS-CoV-2 diagnostic assays are under development by other third parties or have been granted EUA approval by U.S. FDA, any of which may be more successful than the company's assay, and even if the company's assay gains EUA approval, the assay may generate only limited revenue and profits for the company.

ShowHide Related Items >><<
APDN Applied DNA Sciences
$9.10 /

+2.5 (+37.88%)

05/05/20 Maxim
Applied DNA Sciences price target raised to $18 from $8 at Maxim
11/22/19
Fly Intel: Top five analyst upgrades
11/22/19 Maxim
Applied DNA Sciences upgraded to Buy from Hold at Maxim
Recommendations
Applied DNA Sciences price target raised to $18 from $8 at Maxim » 09:03
05/05/20
05/05
09:03
05/05/20
09:03
APDN

Applied DNA Sciences

$9.10 /

+2.5 (+37.88%)

Maxim analyst Anthony…

Maxim analyst Anthony Vendetti raised the firm's price target on Applied DNA Sciences to $18 from $8 and keeps a Buy rating on the shares. The analyst cites the company's announcement yesterday regarding the production of neutralizing antibodies against the COVID-19 virus following the vaccination of DNA in mice. While still pre-clinical, Vendetti contends that the findings mark a "key piece of compelling data" toward a possibility of a viable vaccine candidate.

ShowHide Related Items >><<
APDN Applied DNA Sciences
$9.10 /

+2.5 (+37.88%)

11/22/19
Fly Intel: Top five analyst upgrades
11/22/19 Maxim
Applied DNA Sciences upgraded to Buy from Hold at Maxim

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.